数字PCR检测BRAF V600E和TERT C250T,C228T基因突变对甲状腺结节诊断与预后评估的价值
CSTR:
作者:
作者单位:

郑州金域临床检验中心有限公司

作者简介:

通讯作者:

中图分类号:

基金项目:


Digital PCR for detecting BRAF V600E and TERT C250T,C228T gene mutations and its value in the diagnosis and prognosis evaluation of thyroid nodules
Author:
Affiliation:

Zhengzhou KingMed Clinical Laboratory Co., Ltd.

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨数字聚合酶链式反应(polymerase chain reaction,PCR)技术检测BRAF 原癌基因、丝氨酸/苏氨酸激酶(B-Raf proto-oncogene, serine/threonine kinase,BRAF)V600E 及TERT C250T、C228T 基因突变在甲状腺结节诊断与预后评估中的应用价值。方法 选取2020年1月至2025年12月送检至郑州金域临床检验中心的2 213例甲状腺结节临床样本为研究对象,接受扩增阻滞突变系统聚合酶链式反应(amplification refractory mutation system polymerase chain reaction,ARMS-PCR)和数字PCR 技术检测BRAF V600E 基因突变的样本分别是418 例和1 795 例,并以Sanger 测序或二代测序(next-generation sequencing,NGS)结果作为金标准;其中1 795例患者同时采用数字PCR技术检测TERT C250T 及C228T 基因突变。分析描述两种检测方法的诊断效能,评估数字PCR检测的定量能力、样本适用性及可报告率,并初步探讨突变丰度对预后的评估价值。结果 以金标准结果为参照,在2 213 例甲状腺结节患者样本中,ARMS-PCR 检测BRAF V600E 突变的敏感度为18.71%(159/850),特异度为100%(1 363/1 363);数字PCR检测BRAF V600E 突变的敏感度为为70.82%(602/850),特异度为100%(1 363/1 363)。数字PCR检测到的BRAF V600E 突变拷贝数范围为5.40~77 749.50,野生型拷贝数范围为177.80~181 386.50。数字PCR检测标本类型不仅限于蜡块白片,还有穿刺物,提取DNA浓度经QBIUT检测浓度范围为0.1~112 ng/μl;其中DNA浓度低于检测下限样本为65例,样本可报告率为99.28%。预后评估显示,数字PCR检出的BRAF V600E 高丰度组(≥1.00%)中TERT 突变发生率及淋巴结转移、甲状腺外侵犯风险均显著高于低丰度组,而ARMS-PCR无法提供此类定量预后信息。结论 相比传统ARMS-PCR方法,数字PCR检测BRAF/TERT 基因突变具有更高的敏感度,在检出低丰度突变和处理低质量样本方面有较高的价值,同时其定量能力可为甲状腺结节的预后评估提供重要参考。

    Abstract:

    Objective To explore the application value of digital PCR technology in detecting BRAF V600E and TERT C250T, C228T gene mutations in the diagnosis and prognosis assessment of thyroid nodules. Methods A total of 2, 213 clinical samples of thyroid nodules submitted to Zhengzhou KingMed Clinical Laboratory Center from January 2020 to December 2025 were selected as the research subjects. The samples that underwent both amplification refractory mutation system polymerase chain reaction (ARMS-PCR) and digital PCR techniques for detecting BRAF V600E gene mutations were 418 cases and 1, 795 cases respectively, with sanger sequencing or next-generation sequencing (NGS) results serving as the gold standard. Among them, 1,795 patients also underwent digital PCR testing for TERT C250T and C228T gene mutations. The diagnostic efficacy of the two detection methods was analyzed, and the quantitative ability, sample applicability, and reportability of Digital PCR detection were evaluated. Additionally, the value of mutation abundance in prognosis assessment was preliminarily explored. Results Using the gold standard results as the reference, in 2, 213 samples of thyroid nodules, the sensitivity of ARMS-PCR for detecting BRAF V600E mutations was 70.82% (602/850), with a specificity of 100% (1,363/1,363); the sensitivity of digital PCR for detecting BRAF V600E mutations was 96.94% (824/850), with a specificity of 100% (1,363/1,363). The range of BRAF V600E mutation copy numbers detected by digital PCR was 5.40 -77 749.50, while the range of wild-type copy numbers was 177.80 181,386.50. The specimen types detected by digital PCR were not limited to wax block slides, but also included biopsy specimens. The DNA extraction concentration of the specimens was detected by QBIUT and ranged from 0.1 to 112 ng/μl; among them, 65 samples with DNA concentrations below the detection limit could be reported, and the sample reporting rate was 99.28%. Prognostic assessment showed that in the BRAF V600E high-abundance group (≥1.00%) detected by digital PCR, the incidence of TERT mutations and the risks of lymph node metastasis and extrathyroidal invasion were significantly higher than those in the lowabundance group, while ARMS-PCR could not provide such quantitative prognostic information. Conclusion Compared with the traditional ARMS-PCR method, digital PCR for detecting BRAF/TERT gene mutations has higher sensitivity. It has high value in detecting low-abundance mutations and handling low-quality samples. Moreover, its quantitative ability can provide important reference for the prognosis assessment of thyroid nodules.

    参考文献
    相似文献
    引证文献
引用本文

王小乐.数字PCR检测BRAF V600E和TERT C250T,C228T基因突变对甲状腺结节诊断与预后评估的价值[J].生物医学工程学进展,2026,(3):219-223

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-05-14
  • 最后修改日期:2026-06-15
  • 录用日期:2026-06-16
  • 在线发布日期: 2026-08-19
  • 出版日期:
文章二维码